LabCorp is Scheduled to Present at the 2019 Barclays Global Healthcare Conference Read more about LabCorp is Scheduled to Present at the 2019 Barclays Global Healthcare Conference
LabCorp Strengthens Leadership Position in Precision Medicine with Expansion of Therapeutic Drug Monitoring Portfolio Read more about LabCorp Strengthens Leadership Position in Precision Medicine with Expansion of Therapeutic Drug Monitoring Portfolio
LabCorp Announces 2018 Fourth Quarter and Full Year Results and Provides 2019 Guidance Read more about LabCorp Announces 2018 Fourth Quarter and Full Year Results and Provides 2019 Guidance
LabCorp Named to FORTUNE Magazine's 2019 List of ‘World’s Most Admired Companies,’ Making the Annual List for the Second Consecutive Year Read more about LabCorp Named to FORTUNE Magazine's 2019 List of ‘World’s Most Admired Companies,’ Making the Annual List for the Second Consecutive Year
LabCorp to Announce Fourth Quarter and Full Year 2018 Financial Results on February 7, 2019 Read more about LabCorp to Announce Fourth Quarter and Full Year 2018 Financial Results on February 7, 2019
LabCorp and Texas Association of Community Health Centers Extend Agreement for LabCorp to Be Exclusive Laboratory for Community Health Centers Across Texas Read more about LabCorp and Texas Association of Community Health Centers Extend Agreement for LabCorp to Be Exclusive Laboratory for Community Health Centers Across Texas
Conversion Right Triggered For LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered For LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to an Innovative Diagnostic Assay for Non-Alcoholic Steatohepatitis (NASH) Read more about GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to an Innovative Diagnostic Assay for Non-Alcoholic Steatohepatitis (NASH)
LabCorp is Scheduled to Present at the 37th Annual J.P. Morgan Healthcare Conference Read more about LabCorp is Scheduled to Present at the 37th Annual J.P. Morgan Healthcare Conference
Covance Xcellerate® Wins Best Technological Development in Clinical Trials (Clinical Sponsor-Focused) at 14th Annual Scrip Awards Read more about Covance Xcellerate® Wins Best Technological Development in Clinical Trials (Clinical Sponsor-Focused) at 14th Annual Scrip Awards
